Related Experiment Videos
Novel mutations and polymorphisms in genes causing hereditary hemorrhagic telangiectasia
Salma A Abdalla1, Urszula Cymerman, Diane Rushlow
1Cancer Research Program, The Hospital for Sick Children, and Department of Immunology, University of Toronto, Toronto, Canada M5G 1X8. sabdalla@hotmail.com
Human Mutation
|February 16, 2005
Summary
This study identified 28 mutations in the Endoglin (ENG) and activin receptor-like kinase-1 (ALK1) genes in 31 Hereditary Hemorrhagic Telangiectasia (HHT) families. Novel mutations and a de novo ALK1 mutation were discovered, furthering the understanding of HHT genetics.
Area of Science:
- Genetics
- Molecular Biology
- Vascular Biology
Background:
- Hereditary Hemorrhagic Telangiectasia (HHT) is an autosomal dominant vascular disorder.
- Mutations in Endoglin (ENG) or activin receptor-like kinase-1 (ALK1) genes are known causes of HHT.
Purpose of the Study:
- To perform molecular characterization of HHT-causing genes in affected families.
- To identify novel mutations and polymorphisms in ENG and ALK1 genes.
Main Methods:
- Molecular characterization of 31 HHT families.
- Mutation detection in ENG and ALK1 genes.
- Analysis of novel mutations and polymorphisms.
Main Results:
- Identified 28 different mutations in ENG and ALK1 genes across 31 HHT families.
- Discovered six novel mutations in the ENG gene and eleven novel mutations in the ALK1 gene.
- Reported the first de novo ALK1 mutation (c.1133C>A, p.P378H) associated with gastrointestinal bleeding.
Conclusions:
- Genetic mutations in ENG and ALK1 are confirmed causes of HHT.
- The identification of novel mutations expands the spectrum of known HHT-causing variants.
- Understanding these genetic underpinnings is crucial for diagnosing and managing HHT.